[NCHC] Where is the Value in Overpricing Innovative Treatments?

At $1,000 per pill, the price of the new hepatitis C drug Sovaldi has generated much attention. It’s certainly a breakthrough drug and the type of […]

Read more

[NCHC] AEI Session on Financing Cures: White Hat or White Wash?

On Friday, July 11, AEI is hosting a session entitled “How will we pay for the cost of cures?” On its face this seems like a […]

Read more

[NCHC] New York Joins List of States Outraged Over Sovaldi

Costs to New Yorkers for One Drug Is 4 Times Entire Higher Education Spending A recent article in Capital New York  highlights the dilemma posed by […]

Read more

[POLITICO Pro] 80-group campaign targeting hepatitis drug cost

“More than 80 organizations are launching the Campaign for Sustainable Rx Pricing to bring the pharmaceutical company Gilead to the table to negotiate a lower price, […]

Read more